Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-Shot Exparel Versus Catheters for Lower Extremity Orthopedic Trauma Patients
NCT07221019Phase 4Withdrawn
- Sponsor
- George Washington University
- Start
- Sep 2025
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in pain, sponsored by George Washington University. Planned start Sep 2025; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT07221019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07221019.